Global Bioprosthetics Market By Application (Cardiovascular and Plastic surgery & wound healing), By Product (Allograft, Xenograft, Porcine, and Bovine), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Bioprosthetics Market Overview:

Global bioprosthetics sales were valued at USD 4,656.5 million in 2021. They are expected to increase at a CAGR exceeding 10.2% over the forecast period.

The market base for bioprosthetics is expected to grow due to the increasing incidence of cardiovascular diseases such as rheumatoid heart disease and coronary and peripheral arterial diseases. The market growth is expected to be further boosted by the growing geriatric population, which has a higher risk of developing a degenerative cardiac disease.

Global Bioprosthetics Market Scope:

Application Analysis

The market for bioprosthetics was dominated by the cardiovascular segment, which held a share of more than 87.0%. This rapid growth can be attributed to an increasing number of patients with cardiovascular diseases that require valve replacement.

The incorporation of minimally invasive procedures and the innovative advancements in the second generation of bioprosthetics, which are designed to reduce the number of cases of structural failure, are expected to boost the demand for bio-implants over the forecast period. The dominant share of this segment is due to the fact that open-heart surgery has been less popular since the introduction of bioprosthetic heart valves.

Product Analysis

In 2021, the xenograft market held a significant industry share exceeding 70%. This is due to the many benefits of these implants, including long-term stability and relatively easy availability of raw materials, high survival rates, and simple implantation procedures. It makes it an attractive choice among the other bioprosthetics. Its wide application in areas such as tissue repair and 3D-based personalized implant generation is another reason for its high market share.

The market for porcine-based devices is forecast to grow at a high CAGR over the forecast period. These rapid growth rates can be attributed largely to numerous clinical studies such as the ones conducted by the American Heart Association to improve efficacy and reduce the common adverse effects. All these initiatives are expected to increase the market penetration for porcine xenografts.

Маrkеt Ѕеgmеntѕ

Application:

• Cardiovascular
• Plastic surgery & wound healing

Product:

• Allograft
• Xenograft
• Porcine
• Bovine

Market Dynamics:

Hybrid tissue-engineered bioprostheses have been developed through technological innovation. These include the use of nonbiodegradable cultured tissue scaffolds that contain an alloy of titanium and nickel. They are highly durable alternatives to biodegradable tissue-engineered prosthetics.

These advancements will eventually replace the use of mechanical heart valves that are purely synthetic. They have been associated with high thrombogenicity, so it is necessary to administer anticoagulants to prevent embolic events, valve obstruction, bleeding, and other complications.

These innovative solutions will reduce mortality and morbidity related to cardiac valve disorders. This is expected to increase the market for bioprosthetics during the forecast period. The prostheses will also be stronger due to the use of optimized tissue treatment methods. This will reduce the need for long-term medications that are often associated with prosthetics.

The associated benefits, such as faster recovery rates and a relatively higher patient safety profile, are due to the development of hybrid constructs. These tissue-engineered products also have optimized tissue preservation techniques.

This is expected to increase physician and patient preference for implantable bioprostheses. This market will see lucrative growth opportunities due to the increased preference of the medical community for these prostheses. The market will also benefit from the growing demand for various prostheses due to the increasing number of heart valve diseases and aortic valve replacements.

Regional Analysis

Europe dominated the global bioprosthetics vertical in 2021 with a greater than 38% share. This large share is due to the presence of well-defined reimbursement models, prominent industry figures, and large patient volumes in the region. These devices will be in high demand due to the strict regulatory policies that are being implemented to ensure patient safety and maintain high treatment efficacy standards.

Due to increasing awareness of alternative treatments and rapidly improving healthcare infrastructure, the Asia Pacific bioprosthetics industry is expected to grow at a CAGR exceeding 11.2%. This is due to the high level of research and development in emerging economies like India and China. The growing collaboration between global players in this sector and the government is slowly improving access to healthcare facilities. This will in turn provide the region with high growth potential over the forecast period.

Key Regions and Countries covered in the rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Key Companies & Market share:

To capture more of the vertical, these industry players are pursuing strategies such as mergers and acquisitions. In April 2016, CyroLife, Inc. announced that it had acquired PhotoFix, a bovine tissue patch range, from Genesee BioMedical, Inc. This was done to expand the company’s product line.

Маrkеt Рlауеrѕ іnсludеd in the rероrt:

• LeMaitre Vascular Inc.
• Maquet Metinge Group
• Braile Biomedica, Inc.
• Labcor Laboratorios Ltd.
• Aortech International Plc
• Medtronic Plc.
• Sorin Group
• CryoLife, Inc.
• Other Key Players

For the Bioprosthetics Market research study, the following years have been considered to estimate the market size: